Search research articles
Contact Us
Filters
Showing results (111-120 of 265) with videos related to
Page
of 27
Sort By:
Dermatology (Basel, Switzerland)
|
September 16, 2009
Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis
Kristian Reich, Siegfried Segaert, Peter Van de Kerkhof, et al.
European Journal of Dermatology : EJD
|
April 7, 2020
Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care
Ulrich Mrowietz, Christina Sorbe, Kristian Reich, et al.
Dermatology (Basel, Switzerland)
|
July 15, 2010
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial
Kristian Reich, Jean-Paul Ortonne, Urs Kerkmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 28, 2021
Molecular diagnostics in dermatology: An online survey to study usage, obstacles and requirements in Germany
Linda Tizek, Barbara Schuster, Christoffer Gebhardt, et al.
Journal of the American Academy of Dermatology
|
October 12, 2010
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial
Kristian Reich, James Signorovitch, Karthik Ramakrishnan, et al.
Journal of the American Academy of Dermatology
|
July 6, 2010
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations
Mark Lebwohl, Newman Yeilding, Philippe Szapary, et al.
The Journal of Dermatological Treatment
|
August 18, 2022
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline - a multivariable regression analysis from the German Psoriasis Registry PsoBest
Kristian Reich, Ulrich Mrowietz, Christina Sorbe, et al.
Skin Pharmacology and Physiology
|
September 6, 2025
Effects of a gel containing the defined microalgae extract Spiralin® on the skin microbiome and clinical activity in atopic dermatitis - a double-blind, intraindividual vehicle-controlled proof-of-concept study
Kristian Reich, Natalie Trettel, Jeremias L K Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
March 19, 2022
Molekulardiagnostik in der Dermatologie: Eine Online-Umfrage zur Untersuchung von Nutzung, Hürden und Anforderungen in Deutschland
Linda Tizek, Barbara Schuster, Christoffer Gebhardt, et al.
American Journal of Clinical Dermatology
|
September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study
Kristian Reich, April W Armstrong, Peter Foley, et al.
Page
of 27
Search research articles
Search
Showing results (111-120 of 265) with videos related to
Sort By:
Page
of 27
Dermatology (Basel, Switzerland)
|
September 16, 2009
Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis
Kristian Reich, Siegfried Segaert, Peter Van de Kerkhof, et al.
European Journal of Dermatology : EJD
|
April 7, 2020
Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care
Ulrich Mrowietz, Christina Sorbe, Kristian Reich, et al.
Dermatology (Basel, Switzerland)
|
July 15, 2010
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial
Kristian Reich, Jean-Paul Ortonne, Urs Kerkmann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
December 28, 2021
Molecular diagnostics in dermatology: An online survey to study usage, obstacles and requirements in Germany
Linda Tizek, Barbara Schuster, Christoffer Gebhardt, et al.
Journal of the American Academy of Dermatology
|
October 12, 2010
Benefit-risk analysis of adalimumab versus methotrexate and placebo in the treatment of moderate to severe psoriasis: comparison of adverse event-free response days in the CHAMPION trial
Kristian Reich, James Signorovitch, Karthik Ramakrishnan, et al.
Journal of the American Academy of Dermatology
|
July 6, 2010
Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations
Mark Lebwohl, Newman Yeilding, Philippe Szapary, et al.
The Journal of Dermatological Treatment
|
August 18, 2022
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline - a multivariable regression analysis from the German Psoriasis Registry PsoBest
Kristian Reich, Ulrich Mrowietz, Christina Sorbe, et al.
Skin Pharmacology and Physiology
|
September 6, 2025
Effects of a gel containing the defined microalgae extract Spiralin® on the skin microbiome and clinical activity in atopic dermatitis - a double-blind, intraindividual vehicle-controlled proof-of-concept study
Kristian Reich, Natalie Trettel, Jeremias L K Reich, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
March 19, 2022
Molekulardiagnostik in der Dermatologie: Eine Online-Umfrage zur Untersuchung von Nutzung, Hürden und Anforderungen in Deutschland
Linda Tizek, Barbara Schuster, Christoffer Gebhardt, et al.
American Journal of Clinical Dermatology
|
September 10, 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study
Kristian Reich, April W Armstrong, Peter Foley, et al.
Page
of 27